Department of Microbiology, Nutrition and Dietetics, Faculty of Agrobiology Food and Natural Resources, Czech University of Life Sciences, Prague, Czech Republic.
Anaerobe. 2011 Oct;17(5):223-5. doi: 10.1016/j.anaerobe.2011.07.009. Epub 2011 Aug 5.
For healthy infants, which were born normally and fully breastfed, the dominant component of the intestinal microflora are bifidobacteria. However, infants born by caesarean section possess clostridia as a dominant intestinal bacterial group. The aim of the present study was to determine whether bifidobacteria and clostridia are able to grow on human milk oligosaccharides (HMOs) and other carbon sources - lactose, cow milk (CM) and human milk (HM). Both bifidobacteria and clostridia grew on lactose and in CM. Bifidobacteria grew in HM and on HMOs. In contrast, 3 out of 5 strains of clostridia were not able to grow in HM. No clostridial strain was able to utilise HMOs. While both bifidobacterial strains were resistant to lysozyme, 4 out of 5 strains of clostridia were lysozyme-susceptible. It seems that HMOs together with lysozyme may act as prebiotic-bifidogenic compounds inhibiting intestinal clostridia.
对于正常足月母乳喂养的健康婴儿,肠道微生物群的主要成分为双歧杆菌。然而,剖宫产出生的婴儿肠道细菌群以梭菌为主。本研究旨在确定双歧杆菌和梭菌是否能够在人乳寡糖(HMOs)和其他碳源(乳糖、牛奶(CM)和人乳(HM))上生长。双歧杆菌和梭菌均可在乳糖和 CM 上生长。双歧杆菌在 HM 和 HMOs 上生长。相比之下,5 株梭菌中有 3 株不能在 HM 中生长。没有梭菌能够利用 HMOs。虽然双歧杆菌株均对溶菌酶有抗性,但5 株梭菌中有 4 株对溶菌酶敏感。HMOs 与溶菌酶一起可能作为具有双歧生成作用的益生元化合物,抑制肠道梭菌。